Effect of Repeated Doses of DS-8500a on Pharmacokinetics of Rosuvastatin in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Daiichi Sankyo
Related studies linked through entity extraction aliases.
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Food Effects on Milademetan Pharmacokinetics in Healthy Participants
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy Participants
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Southeast Netherlands Advanced Metastatic Breast Cancer Registry
- Status
- RECRUITING
- Phase
- N/A
Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
- Status
- COMPLETED
- Phase
- PHASE3
Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
- Status
- COMPLETED
- Phase
- PHASE3
DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)
- Status
- COMPLETED
- Phase
- PHASE2
DS-9231 in Intermediate-risk (Sub-massive) Acute Pulmonary Embolism (PE)
- Status
- WITHDRAWN
- Phase
- PHASE2
DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis
- Status
- COMPLETED
- Phase
- PHASE1
CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)
- Status
- COMPLETED
- Phase
- PHASE1
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
- Status
- RECRUITING
- Phase
- N/A
U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1